Literature DB >> 29782316

From Subjective Cognitive Decline to Alzheimer's Disease: The Predictive Role of Neuropsychological Assessment, Personality Traits, and Cognitive Reserve. A 7-Year Follow-Up Study.

Valentina Bessi1, Salvatore Mazzeo1, Sonia Padiglioni1, Carolina Piccini2, Benedetta Nacmias1, Sandro Sorbi1,3, Laura Bracco1.   

Abstract

The aim of this study was to evaluate the accuracy of neuropsychological assessment in predicting conversion from subjective cognitive decline (SCD) and mild cognitive impairment (MCI) to Alzheimer's disease (AD) and the effect of personality traits and cognitive reserve in progression from SCD to MCI. As part of a longitudinal, clinical-neuropsychological-genetic survey on SCD and MCI, 284 patients referred to our hospital between 1990 and 2017 were included. All patients underwent clinical-extensive neuropsychological evaluation and Apolipoprotein E genotyping; personality traits were assessed in a subgroup. Each patient underwent clinical-neuropsychological follow-up. Subjects with a follow-up shorter than two years were excluded. A total of 212 subjects were, after exclusions, considered: 26 out of 109 SCD subjects progressed to MCI (SCD-p), 15 converted to AD (SCD-c), and 68 remained stable (SCD-s). Of 103 MCI subjects, 39 converted to AD (MCI-c) and 64 remained stable (MCI-s). At baseline, SCD-c performed significantly worse than SCD-s in tests assessing long-term verbal memory. MCI-c showed worse performance on neuropsychological tests for short- and long-term verbal memory and for ecological evaluation of memory (RBMT). These tests provided good accuracy in distinguishing MCI-c and MCI-s. Emotional stability was significantly lower in SCD-s than in SCD-p while higher intellectual activities were associated with a lower risk of conversion to MCI. Our results suggest that memory neuropsychological tests may represent a reliable tool to estimate the risk of progression to AD. Personality and lifestyle factors could provide useful information to identify SCD subjects who may develop an objective cognitive impairment.

Entities:  

Keywords:  APOE; Alzheimer’s disease; cognitive reserve; dementia; mild cognitive zzm321990impairment; neuropsychology; personality traits; prediction; subjective cognitive decline

Mesh:

Substances:

Year:  2018        PMID: 29782316     DOI: 10.3233/JAD-171180

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  14 in total

Review 1.  Brain Structural and Functional Changes in Cognitive Impairment Due to Alzheimer's Disease.

Authors:  Marina Ávila-Villanueva; Alberto Marcos Dolado; Jaime Gómez-Ramírez; Miguel Fernández-Blázquez
Journal:  Front Psychol       Date:  2022-06-21

2.  Protective factors for subjective cognitive decline individuals: trajectories and changes in a longitudinal study with Italian elderly.

Authors:  Sara Mondini; Veronica Pucci; Sonia Montemurro; Raffaella Ida Rumiati
Journal:  Eur J Neurol       Date:  2021-12-05       Impact factor: 6.288

3.  Impact of Apolipoprotein E gene polymorphism during normal and pathological conditions of the brain across the lifespan.

Authors:  Diego Iacono; Gloria C Feltis
Journal:  Aging (Albany NY)       Date:  2019-01-24       Impact factor: 5.682

4.  Sino Longitudinal Study on Cognitive Decline (SILCODE): protocol for a Chinese longitudinal observational study to develop risk prediction models of conversion to mild cognitive impairment in individuals with subjective cognitive decline.

Authors:  Xuanyu Li; Xiaoni Wang; Li Su; Xiaochen Hu; Ying Han
Journal:  BMJ Open       Date:  2019-07-26       Impact factor: 2.692

5.  Memory Complaint Is a Surrogate for Memory Decline in the Middle-Aged: A Register-Based Study.

Authors:  Yah-Yuan Wu; Wen-Chuin Hsu; Yu-Hua Huang; Wei-Min Ho; Yi-Chun Chen
Journal:  J Clin Med       Date:  2019-11-07       Impact factor: 4.241

6.  Dual Effect of PER2 C111G Polymorphism on Cognitive Functions across Progression from Subjective Cognitive Decline to Mild Cognitive Impairment.

Authors:  Salvatore Mazzeo; Valentina Bessi; Silvia Bagnoli; Giulia Giacomucci; Juri Balestrini; Sonia Padiglioni; Giulia Tomaiuolo; Assunta Ingannato; Camilla Ferrari; Laura Bracco; Sandro Sorbi; Benedetta Nacmias
Journal:  Diagnostics (Basel)       Date:  2021-04-18

7.  Evaluation of neurotrophic factors and education level as predictors of cognitive decline in alcohol use disorder.

Authors:  Nerea Requena-Ocaña; Pedro Araos; María Flores; Nuria García-Marchena; Daniel Silva-Peña; Jesús Aranda; Patricia Rivera; Juan Jesús Ruiz; Antonia Serrano; Francisco Javier Pavón; Juan Suárez; Fernando Rodríguez de Fonseca
Journal:  Sci Rep       Date:  2021-08-02       Impact factor: 4.379

8.  Effect of APOEε4 on Functional Brain Network in Patients with Subjective Cognitive Decline: A Resting State Functional MRI Study.

Authors:  Simin Deng; Lingyu Sun; Weijie Chen; Xiaorong Liu; Shangjie Chen
Journal:  Int J Gen Med       Date:  2021-12-14

Review 9.  Questions concerning the role of amyloid-β in the definition, aetiology and diagnosis of Alzheimer's disease.

Authors:  Gary P Morris; Ian A Clark; Bryce Vissel
Journal:  Acta Neuropathol       Date:  2018-10-22       Impact factor: 17.088

10.  Transcranial Pulse Stimulation with Ultrasound in Alzheimer's Disease-A New Navigated Focal Brain Therapy.

Authors:  Roland Beisteiner; Eva Matt; Christina Fan; Heike Baldysiak; Marleen Schönfeld; Tabea Philippi Novak; Ahmad Amini; Tuna Aslan; Raphael Reinecke; Johann Lehrner; Alexandra Weber; Ulrike Reime; Cédric Goldenstedt; Ernst Marlinghaus; Mark Hallett; Henning Lohse-Busch
Journal:  Adv Sci (Weinh)       Date:  2019-12-23       Impact factor: 16.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.